Aligos Therapeutics, Inc.
MODIFIED GAPMER OLIGONUCLEOTIDES AND METHODS OF USE
Last updated:
Abstract:
The disclosure includes antisense oligonucleotides, including gapmer antisense oligonucleotides, along with methods of making and use, e.g., against HBV.
Status:
Application
Type:
Utility
Filling date:
29 May 2020
Issue date:
10 Dec 2020